Navigation Links
Isis Reports New Data for Mipomersen in Routine High Cholesterol Patients and Provides Cumulative Safety Summary
Date:11/13/2007

een mild to moderate injection site reactions, which represent cosmetic inconveniences rather than safety concerns. We have not observed elevations in liver enzymes associated with increases in bilirubin or other signs or symptoms of liver dysfunction. During treatment and follow-up periods, subjects who received 200 mg/week mipomersen, our Phase 3 dose, experienced mild ALT elevations of 3-5xULN, similar to those in subjects who received placebo. These data are particularly impressive when one considers the fact that every subject was evaluated weekly and all ALT elevations were counted, whether confirmed or not. Based on this experience, we are very encouraged by mipomersen's overall safety and efficacy profile," concluded Dr. Jonas.

Table 1: Mipomersen in Routine High Cholesterol Patients Coadministered

with Statins

Summary of Results. Median % changes from baseline at primary endpoint.*

Per Placebo 30 100 200 300 400** 200***

Protocol mg/week mg/week mg/week mg/week mg/week mg/week

5 weeks 5 weeks 5 weeks 5 weeks 5 weeks 13 weeks

# of

patients 11 8 8 16 8 8 8

ApoB -1% 0% -20% -24% -52% -51% -42%

(p=0.80) (p=0.03) (p=0.004) (p<0.0001)(p=0.0004)(p<0.0001)

LDL-C -4% 4% -22% -30% -51% -47% -48%

(p=0.31) (p=0.01) (p=0.002) (p<0.0001) (p=0.008)(p<0.0001)

VLDL-C 7% 8% 10% -25% -63% -69% -17%

(p=0.84) (p=0.66) (p=0.38) (p=0.08) (p=0.02) (p=0.80)

Non-HDL-C -1% 8% -20% -22% -51% -49% -30%

(p=0.44) (p=0.02) (p=0.02) (p<0.0001) (p=0.008) (p=0.006)

HDL-C 9% 1% -4% 6% 5% 6% -4%


'/>"/>

SOURCE Isis Pharmaceuticals, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
2. Spherix Reports Second Quarter Earnings
3. Tapestry Reports Second Quarter 2007 Results
4. Callisto Reports on Second-Quarter 2007 Milestones
5. ImmuneRegen BioSciences Reports Material Transfer Agreement with VaxGen, Inc.
6. Vical Reports Second Quarter 2007 Financial Results, Allowance of Pandemic Influenza IND and Other Advances in Product Development Programs
7. Paper in International Journal of Oncology Reports Alfacells ONCONASE(R) Suppresses Intracellular Oxidative Stress
8. TAXUS WOMAN Study Reports Positive Clinical Outcomes for the TAXUS(R) Drug-eluting Stent in Women
9. Biopure Reports on Meeting with the FDA
10. Peregrine Reports Data Showing Bavituximabs Potential to Shrink Prostate Tumors
11. NicOx Reports TOPIGEN to Advance TPI-1020 Into Phase 2 for COPD Following Promising Clinical Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/31/2015)... 2015 Regen BioPharma, Inc. (OTCBB: RGBP) ... novel means of delivering its patented (US Patent ... tumors utilizing a clinically approved formulation as delivery ... with gene silencing therapeutics in which the gene ... whole body.  By utilizing a local delivery system, ...
(Date:8/31/2015)... and MOUNTAIN VIEW, Calif. , Aug. ... ; EURONEXT: SAN) and the life sciences team at ... care and outcomes for people with type 1 and ... treatments and devices with Google,s expertise in analytics, miniaturized ... explore how to improve diabetes care by developing new ...
(Date:8/31/2015)...  Qualcomm Incorporated (NASDAQ: QCOM ) today ... is collaborating with Davita Healthcare Partners and ... by Qualcomm Life,s 2net™ Device Connectivity Platform and ... informed interventions and better management of at-risk populations. ... Connect 2015 ecosystem conference taking place ...
Breaking Medicine Technology:Regen BioPharma, Inc. Develops BORIS Gene Silencing Based Treatment for Unresectable Liver Cancer 2Regen BioPharma, Inc. Develops BORIS Gene Silencing Based Treatment for Unresectable Liver Cancer 3Sanofi to Collaborate with Google Life Sciences to Improve Diabetes Health Outcomes 2Sanofi to Collaborate with Google Life Sciences to Improve Diabetes Health Outcomes 3Sanofi to Collaborate with Google Life Sciences to Improve Diabetes Health Outcomes 4Sanofi to Collaborate with Google Life Sciences to Improve Diabetes Health Outcomes 5Sanofi to Collaborate with Google Life Sciences to Improve Diabetes Health Outcomes 6Qualcomm Life Announces New Connected Health Collaborations at Connect 2015 2Qualcomm Life Announces New Connected Health Collaborations at Connect 2015 3Qualcomm Life Announces New Connected Health Collaborations at Connect 2015 4Qualcomm Life Announces New Connected Health Collaborations at Connect 2015 5
... 7, 2011  Tethys Bioscience has entered into an agreement ... employers measurably flatten the trajectory of their healthcare trends ... their employee populations. The agreement allows ACAP Health to ... as a component of its disease intervention programs. The ...
... 2011 Ampio Pharmaceuticals, Inc. (NASDAQ: AMPE ... and develops new uses for previously approved drugs and ... of the granting of a European patent with broad ... diketopiperazine which is the active ingredient of Ampion™.  The ...
Cached Medicine Technology:Tethys Bioscience and ACAP Health Consulting Partner to Help Employers Prevent Diabetes 2Tethys Bioscience and ACAP Health Consulting Partner to Help Employers Prevent Diabetes 3Ampio Pharmaceuticals Awarded European Patent that Strengthens Intellectual Property Protection for its key drug Ampion™ 2
(Date:9/1/2015)... ... 01, 2015 , ... AdvantagePlusCaregivers.com® provides information on defining what ... to look for and expect when searching for resources, as well as a ... Park, CA by CEO, Richard Weatherman and Co-Founder Piroska Zalkadi, AdvantagePlusCaregivers.com® grew exponentially ...
(Date:9/1/2015)... ... September 01, 2015 , ... ... Network, the Premier Outcomes-Driven Provider Network. It is the first-ever, standardized, outcomes-driven ... the provision of quality addiction treatment and the utilization of resources to ...
(Date:9/1/2015)... ... 2015 , ... The integration of Practice Perfect and FOTO ... to FOTO enabling cost and time savings, reducing errors and omissions, and eliminating ... Practice Perfect, stated "FOTO is a natural extension of Practice Perfect, assisting ...
(Date:9/1/2015)... ... 2015 , ... Elizabeth Callahan, MD, founder and medical director of SkinSmart ... offer RADIESSE® filler treatment for volume loss in the hands. RADIESSE provides an immediate ... the hands, delivering smooth, natural-looking results that can last up to one year in ...
(Date:9/1/2015)... ... 2015 , ... Routines… every family has them. Whether it’s a morning routine, ... parents, caregivers and children too. Here are three reasons why routines can be beneficial ... fluid. When a routine is implemented into a child’s schedule, they are able to ...
Breaking Medicine News(10 mins):Health News:AdvantagePlusCaregivers.com® Launches New Website for Corporate and Franchisee Locations in 3 States 2Health News:MAP Health Management Launches the MAP Recovery Network 2Health News:FOTO Announces New Integration Partnership with Practice Perfect 2Health News:SkinSmart Dermatology in Sarasota is Now Offering RADIESSE to Rejuvenate Hands 2Health News:SkinSmart Dermatology in Sarasota is Now Offering RADIESSE to Rejuvenate Hands 3Health News:Back into the Swing of Things: How Family Routines Benefit Children 2
... say , , MONDAY, Sept. 22 (HealthDay News) -- Poorer ... much longer to get to the hospital when a heart ... finds. , The finding suggests that patients without means may ... for time-sensitive care following a heart attack, the researchers noted. ...
... Remains Unchanged, BETHESDA, Md., Sept. 22 Hanger ... public offering of 2,500,000,shares of its common stock by ... a portion of the currently outstanding shares,issued to Ares ... all of,Hanger,s Series A Convertible Preferred Stock into common ...
... SACRAMENTO, Calif., Sept. 22 The California Office of,Traffic Safety ... riding in car safety seats. The 2008 rate of 94.4 ... a big jump of 6.7,percentage points over the 2007 rate ... time to kick off the national Child,Passenger Safety Week, September ...
... WASHINGTON, Sept. 22 An improved and more,accessible ... to help,people stay healthy, was launched today by ... Its new design and interactive health management ... use for consumers and,professionals., "Many Americans struggle ...
... computer model, it appears that comparing the benefits and ... women and their physicians choose appropriate screening strategies, according ... Archives of Internal Medicine , one of the ... commonly known as Pap smears, is credited with reducing ...
... Patients on statin medications 30% more likely to experience ... -- People who are taking cholesterol-lowering statin drugs -- ... more likely to suffer delirium after surgery, a Canadian ... neglected, experience for older people after any sort of ...
Cached Medicine News:Health News:Heart Attack Care Often Delayed for the Poor 2Health News:Heart Attack Care Often Delayed for the Poor 3Health News:Hanger Orthopedic Group, Inc. Announces Underwritten Public Offering by Shareholder 2Health News:Hanger Orthopedic Group, Inc. Announces Underwritten Public Offering by Shareholder 3Health News:Record Upsurge in State's Child Safety Seat Usage Marks Child Passenger Safety Week 2Health News:Improved healthfinder.gov Makes Health Information Quicker and Easier to Use 2Health News:Improved healthfinder.gov Makes Health Information Quicker and Easier to Use 3Health News:Model highlights benefits and risks of cervical cancer screening methods 2Health News:Cholesterol Drugs May Raise Post-Op Delirium Risk 2Health News:Cholesterol Drugs May Raise Post-Op Delirium Risk 3
Open blade design with aspiration capabilities for removing fluids from the operative site. 19 gauge wire....
Designed to provide open approaches of the keratome to the cornea for either the left or right eye. Lightweight wire design adds to the comfort of the instrument when in place....
Solid 14 mm free-swinging blades, suture posts, and stabilizing disk. Dull finish....
Designed for use with foster enucleation snare (E3670). Package of 12 stainless steel wires. Overall length 5.3 inches....
Medicine Products: